AP385A - Benzopyrans and related LTB4 antagonists. - Google Patents
Benzopyrans and related LTB4 antagonists. Download PDFInfo
- Publication number
- AP385A AP385A APAP/P/1992/000441A AP9200441A AP385A AP 385 A AP385 A AP 385A AP 9200441 A AP9200441 A AP 9200441A AP 385 A AP385 A AP 385A
- Authority
- AP
- ARIPO
- Prior art keywords
- alkyl
- phenyl
- compound
- hydrogen
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
- C07C255/13—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82467892A | 1992-01-23 | 1992-01-23 | |
| US89005592A | 1992-05-28 | 1992-05-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9200441A0 AP9200441A0 (en) | 1993-01-31 |
| AP385A true AP385A (en) | 1995-05-15 |
Family
ID=27124835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1992/000441A AP385A (en) | 1992-01-23 | 1992-11-10 | Benzopyrans and related LTB4 antagonists. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5550152A (de) |
| EP (1) | EP0623122B1 (de) |
| JP (1) | JP2813464B2 (de) |
| KR (1) | KR950700274A (de) |
| CN (1) | CN1074681A (de) |
| AP (1) | AP385A (de) |
| AT (1) | ATE149493T1 (de) |
| AU (1) | AU2773392A (de) |
| BG (1) | BG98873A (de) |
| BR (1) | BR9207064A (de) |
| CA (1) | CA2117349C (de) |
| CZ (1) | CZ395492A3 (de) |
| DE (1) | DE69217998T2 (de) |
| DK (1) | DK0623122T3 (de) |
| ES (1) | ES2098547T3 (de) |
| FI (1) | FI943473A7 (de) |
| GR (1) | GR3022999T3 (de) |
| HU (1) | HUT67929A (de) |
| IL (1) | IL104421A0 (de) |
| IS (1) | IS3968A (de) |
| MX (1) | MX9300313A (de) |
| NO (1) | NO942758L (de) |
| OA (1) | OA10713A (de) |
| PT (1) | PT101182A (de) |
| TW (1) | TW213456B (de) |
| UY (1) | UY23537A1 (de) |
| WO (1) | WO1993015066A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9300312A (es) * | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
| NZ285154A (en) * | 1994-10-13 | 1998-11-25 | Pfizer | Optionally heterocyclically substituted benzopyran and benzo-fused derivatives, preparation and use as leukotriene antagonists |
| RU2128655C1 (ru) | 1994-10-13 | 1999-04-10 | Пфайзер Инк. | Бензопирановые и бензоконденсированные соединения, промежуточные соединения, фармацевтическая композиция и способ ингибирования |
| DK0925292T3 (da) * | 1996-09-16 | 2004-01-12 | Pfizer | Fremgangsmåder og mellemprodukter til fremstilling af substituerede chromanolderivater |
| US6416733B1 (en) | 1996-10-07 | 2002-07-09 | Bristol-Myers Squibb Pharma Company | Radiopharmaceuticals for imaging infection and inflammation |
| IL121931A (en) * | 1996-10-17 | 2000-02-17 | Pfizer | Pharmaceutical compositions for preventing allograft rejection |
| EP0963755A3 (de) * | 1998-04-16 | 2001-03-14 | Pfizer Products Inc. | Verwendung von Benzopyrane zur Verhinderung von Abstossungsreaktionen allogener Transplantate |
| CA2427911A1 (en) | 2000-11-03 | 2002-05-10 | Bristol Myers Squibb Company | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| US6541613B2 (en) * | 2000-12-15 | 2003-04-01 | Uyrex Corporation | Isoflavone derivatives |
| US6958156B2 (en) * | 2000-12-15 | 2005-10-25 | Vyrex Corporation | Isoflavone derivatives |
| MXPA03006876A (es) * | 2001-01-30 | 2003-11-13 | Pfizer Prod Inc | Intermedios y procedimientos para preparar derivados de cromanol sustituido. |
| JP2008506768A (ja) * | 2004-07-22 | 2008-03-06 | ファルマシア コーポレーション | Cox−2選択的阻害剤とltb4受容体アンタゴニストを組み合わせて用いる炎症および疼痛を治療するための組成物 |
| KR101107800B1 (ko) * | 2006-10-31 | 2012-01-25 | 화이자 프로덕츠 인코포레이티드 | 무기질코르티코이드 수용체 길항제로서의 피라졸린 화합물 |
| CN104710438B (zh) * | 2013-12-11 | 2019-11-29 | 中国科学院上海药物研究所 | 促进iPS细胞产生的螺环类化合物及其制备方法和用途 |
| US10849954B2 (en) * | 2014-11-11 | 2020-12-01 | Juntendo Educational Foundation | Preventive or therapeutic agent for age-related macular degeneration |
| US10029995B2 (en) | 2015-09-03 | 2018-07-24 | Forma Therapeutics, Inc. | [6,6] fused bicyclic HDAC8 inhibitors |
| WO2017095722A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
| EP3383868B1 (de) | 2015-11-30 | 2022-10-05 | Merck Sharp & Dohme LLC | Arylsulfonamide als blt1-antagonisten |
| WO2017095725A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl sulfonamides as blt1 antagonists |
| EP3383389B1 (de) | 2015-11-30 | 2021-04-28 | Merck Sharp & Dohme Corp. | Arylacylsulfonamide als blt1-antagonisten |
| CN109289091B (zh) * | 2018-10-09 | 2021-04-13 | 温州医科大学附属第一医院 | 一种用于装载骨髓间充质干细胞的复合支架及其制备方法 |
| CN111647003B (zh) * | 2020-06-08 | 2022-06-21 | 中国科学院昆明植物研究所 | 三环氧六氢色酮a及其药物组合物和其应用 |
| CN111671745A (zh) * | 2020-07-29 | 2020-09-18 | 北京大学 | 化合物在治疗溃疡性结肠炎药物制备中的应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0276064A1 (de) * | 1987-01-12 | 1988-07-27 | Eli Lilly And Company | Entzündungshemmende Mittel |
| EP0404440A2 (de) * | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Substituierte Sulfonamide und verwandte Verbindungen zur Behandlung von Asthma, Arthritis und verwandten Krankheiten |
| US5059609A (en) * | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
-
1992
- 1992-10-13 ES ES92921463T patent/ES2098547T3/es not_active Expired - Lifetime
- 1992-10-13 BR BR9207064A patent/BR9207064A/pt not_active Application Discontinuation
- 1992-10-13 AU AU27733/92A patent/AU2773392A/en not_active Abandoned
- 1992-10-13 FI FI943473A patent/FI943473A7/fi unknown
- 1992-10-13 CA CA002117349A patent/CA2117349C/en not_active Expired - Lifetime
- 1992-10-13 US US08/256,809 patent/US5550152A/en not_active Expired - Lifetime
- 1992-10-13 WO PCT/US1992/008555 patent/WO1993015066A1/en not_active Ceased
- 1992-10-13 HU HU9402163A patent/HUT67929A/hu unknown
- 1992-10-13 AT AT92921463T patent/ATE149493T1/de not_active IP Right Cessation
- 1992-10-13 CZ CS923954A patent/CZ395492A3/cs unknown
- 1992-10-13 EP EP92921463A patent/EP0623122B1/de not_active Expired - Lifetime
- 1992-10-13 DE DE69217998T patent/DE69217998T2/de not_active Expired - Lifetime
- 1992-10-13 JP JP5513182A patent/JP2813464B2/ja not_active Expired - Fee Related
- 1992-10-13 DK DK92921463.3T patent/DK0623122T3/da active
- 1992-10-17 TW TW081108272A patent/TW213456B/zh active
- 1992-11-10 AP APAP/P/1992/000441A patent/AP385A/en active
-
1993
- 1993-01-18 IL IL104421A patent/IL104421A0/xx unknown
- 1993-01-18 UY UY23537A patent/UY23537A1/es unknown
- 1993-01-19 IS IS3968A patent/IS3968A/is unknown
- 1993-01-20 CN CN93100695A patent/CN1074681A/zh active Pending
- 1993-01-22 PT PT101182A patent/PT101182A/pt not_active Application Discontinuation
- 1993-01-22 MX MX9300313A patent/MX9300313A/es unknown
-
1994
- 1994-06-24 BG BG98873A patent/BG98873A/xx unknown
- 1994-07-22 OA OA60544A patent/OA10713A/en unknown
- 1994-07-22 NO NO942758A patent/NO942758L/no unknown
- 1994-07-23 KR KR1019940702540A patent/KR950700274A/ko not_active Ceased
-
1997
- 1997-04-01 GR GR970400673T patent/GR3022999T3/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0276064A1 (de) * | 1987-01-12 | 1988-07-27 | Eli Lilly And Company | Entzündungshemmende Mittel |
| US5059609A (en) * | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| EP0404440A2 (de) * | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Substituierte Sulfonamide und verwandte Verbindungen zur Behandlung von Asthma, Arthritis und verwandten Krankheiten |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2117349C (en) | 2000-02-29 |
| FI943473A0 (fi) | 1994-07-22 |
| DK0623122T3 (da) | 1997-04-21 |
| TW213456B (de) | 1993-09-21 |
| JP2813464B2 (ja) | 1998-10-22 |
| NO942758D0 (no) | 1994-07-22 |
| ATE149493T1 (de) | 1997-03-15 |
| CN1074681A (zh) | 1993-07-28 |
| EP0623122A1 (de) | 1994-11-09 |
| AP9200441A0 (en) | 1993-01-31 |
| UY23537A1 (es) | 1993-06-28 |
| NO942758L (no) | 1994-07-22 |
| MX9300313A (es) | 1994-06-30 |
| DE69217998D1 (de) | 1997-04-10 |
| PT101182A (pt) | 1994-03-31 |
| US5550152A (en) | 1996-08-27 |
| FI943473L (fi) | 1994-07-22 |
| ES2098547T3 (es) | 1997-05-01 |
| AU2773392A (en) | 1993-09-01 |
| JPH07503464A (ja) | 1995-04-13 |
| KR950700274A (ko) | 1995-01-16 |
| GR3022999T3 (en) | 1997-07-30 |
| IL104421A0 (en) | 1993-05-13 |
| OA10713A (en) | 2002-12-04 |
| IS3968A (is) | 1993-07-24 |
| WO1993015066A1 (en) | 1993-08-05 |
| HUT67929A (en) | 1995-05-29 |
| CA2117349A1 (en) | 1993-08-05 |
| DE69217998T2 (de) | 1997-06-12 |
| BR9207064A (pt) | 1995-12-19 |
| HU9402163D0 (en) | 1994-09-28 |
| BG98873A (bg) | 1995-03-31 |
| FI943473A7 (fi) | 1994-07-22 |
| CZ395492A3 (en) | 1994-03-16 |
| EP0623122B1 (de) | 1997-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP385A (en) | Benzopyrans and related LTB4 antagonists. | |
| CA2438961C (en) | Beta-lactam compounds, manufacturing methods of the compounds and serum hypocholesterolemic agents containing the compounds | |
| JP2983295B2 (ja) | ベンゾピランおよびベンゾ縮合した化合物、それらの製造方法ならびにロイコトリエンb▲下4▼(ltb▲下4▼)アンタゴニストとしてのそれらの使用 | |
| US5939452A (en) | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists | |
| JP2765757B2 (ja) | ベンゾピラン及び関連のltb▲下4▼アンタゴニスト | |
| JPH10120635A (ja) | 医薬化合物 | |
| US6441173B1 (en) | Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives | |
| US5104868A (en) | Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters | |
| HK1000245B (en) | Benzopyran and related ltb4-antagonists |